Cardiff Oncology Inc (CRDF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 245 | 378 | 505 | 381 | 313 |
| Cost of Goods | N/A | 598 | 1,811 | 1,731 | 629 |
| Gross Profit | 245 | -219 | -1,306 | -1,349 | -316 |
| Operating Expenses | 16,923 | 17,432 | 25,101 | 39,527 | 25,587 |
| Operating Income | -16,679 | -17,053 | -25,596 | -40,146 | -25,274 |
| Interest Expense | 0 | 25 | 1,034 | 1,674 | 1,468 |
| Other Income | 264 | 618 | 1,723 | 2,616 | -729 |
| Pre-tax Income | -16,414 | -16,461 | -24,907 | -39,204 | -27,471 |
| Net Income Continuous | -16,414 | -16,461 | -24,907 | -39,204 | -27,471 |
| Net Income | $-16,414 | $-16,461 | $-24,907 | $-39,204 | $-27,471 |
| EPS Basic Total Ops | -2.80 | -8.26 | -51.76 | -93.62 | -75.62 |
| EPS Basic Continuous Ops | -2.75 | -7.06 | -51.67 | -93.56 | -75.50 |
| EPS Diluted Total Ops | -2.80 | -8.26 | -51.76 | -98.66 | -87.14 |
| EPS Diluted Continuous Ops | -2.75 | -7.06 | -51.67 | -93.23 | -74.79 |
| EPS Diluted Before Non-Recurring Items | -2.80 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-16,184 | $-16,194 | $-24,225 | $-38,578 | $-24,549 |